Labcorp executive receives stock awards, covers taxes

LABCORP HOLDINGS INC. executive Brian J. Caveney, EVP and President of Enterprise Diagnostics, CMO & CSO, reported stock-based compensation and related tax withholding.

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive Brian J. Caveney, EVP and President of Enterprise Diagnostics, CMO & CSO, reported stock-based compensation and related tax withholding. On March 26, 2026, he acquired 9,304 and 1,986 shares of common stock from performance awards tied to the three-year period ended December 31, 2025. To satisfy tax withholding obligations, 4,042 and 863 shares were withheld at $268.38 per share. After these transactions, he directly owned 36,491.9234 shares of Labcorp common stock.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Caveney Brian J

Role EVP, Pres of ED, CMO & CSO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,304	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	4,042	$268.38	$1.08M
Grant/Award	Common Stock	1,986	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	863	$268.38	$232K

Holdings After Transaction: Common Stock — 36,491.9234 shares (Direct)

Footnotes (3)

1. F1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
2. F2. Stock withholding to satisfy tax withholding obligations.
3. F3. Shares acquired on March 26, 2026, pursuant to a performance award granted on May 5, 2023, relating to performance during the three-year period ended December 31, 2025.

Key Figures

Performance award shares (grant 1): 9,304 shares Performance award shares (grant 2): 1,986 shares Shares withheld for taxes: 4,905 shares +2 more

5 metrics

Performance award shares (grant 1) 9,304 shares Common stock acquired March 26, 2026 via performance award for period ending December 31, 2025

Performance award shares (grant 2) 1,986 shares Common stock acquired March 26, 2026 via performance award for period ending December 31, 2025

Shares withheld for taxes 4,905 shares Aggregate stock withholding to satisfy tax obligations on March 26, 2026

Withholding price $268.38 per share Price used in tax withholding dispositions (code F) on March 26, 2026

Post-transaction holdings 36,491.9234 shares Labcorp common stock directly owned after transactions on March 26, 2026

Key Terms

performance award, stock withholding, tax withholding obligations, Form 4

4 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025"

stock withholding financial

"Stock withholding to satisfy tax withholding obligations."

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Labcorp (LH) executive Brian Caveney report in this Form 4?

Brian J. Caveney reported stock-based compensation awards and related tax withholding. He received common shares from performance awards and had a portion of those shares withheld to cover tax obligations, with his direct Labcorp ownership updated after these transactions.

How many Labcorp (LH) shares did Brian Caveney acquire in the awards?

He acquired 9,304 and 1,986 Labcorp common shares through performance awards. These awards were granted in 2023 and were tied to company performance over the three-year period ending December 31, 2025, before any tax withholding was applied.

How many Labcorp (LH) shares were withheld for Brian Caveney’s taxes?

A total of 4,905 shares were withheld to satisfy tax obligations, consisting of 4,042 and 863 shares. The withholding transactions were priced at $268.38 per share, reflecting non-market dispositions used specifically to cover required tax liabilities.

What is Brian Caveney’s Labcorp (LH) share ownership after these transactions?

After the reported awards and tax withholding, Brian J. Caveney directly owned 36,491.9234 Labcorp common shares. This figure reflects his updated direct holdings following both the performance-based share acquisitions and the stock withholding for tax obligations.

Were Brian Caveney’s Labcorp (LH) transactions open-market buys or sells?

No, the filing shows compensation-related share grants and tax withholding dispositions, not open-market trading. Code A entries reflect stock awards, while code F entries indicate shares withheld to pay taxes rather than discretionary purchases or sales in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 12:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caveney Brian J

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Pres of ED, CMO & CSO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		A(1)		9,304	A	$0	39,410.9234	D
Common Stock	03/26/2026		F(2)		4,042	D	$268.38	35,368.9234	D
Common Stock	03/26/2026		A(3)		1,986	A	$0	37,354.9234	D
Common Stock	03/26/2026		F(2)		863	D	$268.38	36,491.9234	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

3. Shares acquired on March 26, 2026, pursuant to a performance award granted on May 5, 2023, relating to performance during the three-year period ended December 31, 2025.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)